Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | KAT6A | Q92794 | 9/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11484961 | 0.98 | MAPT (0.46) | MAPTALDH1A1TSHRNOTUMGRM5 | |
| SCHEMBL873113 | 0.91 | MAPT (0.53) | MAPTALDH1A1NOTUMGRM5KAT6A | |
| SCHEMBL14964128 | 0.87 | MAPT (0.49) | MAPTALDH1A1NOTUMGRM5KAT6A | |
| SCHEMBL14955783 | 0.87 | NOTUM (0.48) | MAPTALDH1A1NOTUMKDM4EKMT2A | |
| SCHEMBL23702605 | 0.79 | NOTUM (0.42) | MAPTALDH1A1NOTUMKDM4EKMT2A | |
| SCHEMBL526836 | 0.79 | ALDH1A1 (0.47) | MAPTALDH1A1NOTUMGRM5KAT6A | |
| SCHEMBL16787410 | 0.79 | KAT6A (0.46) | MAPTALDH1A1NOTUMGRM5KAT6A | |
| SCHEMBL221069 | 0.79 | ADORA2A (0.42) | MAPTALDH1A1NOTUMKDM4EKMT2A | |
| SCHEMBL15652439 | 0.79 | NOTUM (0.42) | MAPTALDH1A1NOTUMKDM4EKMT2A | |
| SCHEMBL6209994 | 0.79 | MAPT (0.43) | MAPTALDH1A1NOTUMGRM5KAT6A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024078513-A1 | CONDENSED AZINES FOR TREATING CANCER | CHENGDU ANTICANCER BIOSCIENCE , LTD. (CN) | 2024-04-18 | — | — | WO | disclosed |
| WO-2021152165-A1 | MACROCYCLIC RIP2-KINASE INHIBITORS | ONCODESIGN S.A. (FR) | 2021-08-05 | — | — | WO | disclosed |
| WO-2017060873-A1 | SUBSTITUTED PYRAZOLO[3,4-B]PYRIDIN-6-CARBOXYLIC ACIDS AND THEIR USE | AbbVie S.à.r.l. (LU) | 2017-04-13 | — | — | WO | disclosed |
| EP-2812346-A1 | LIGANDS FOR ANTIBODY AND FC-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMOTOGRAPHY IV | Graffinity Pharmaceuticals GmbH (DE) | 2014-12-17 | — | — | EP | disclosed |
| US-8778942-B2 | Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitors | ARIAD PHARMACEUTICALS, INC. (US) | 2014-07-15 | — | — | US | disclosed |
| WO-2013117707-A1 | LIGANDS FOR ANTIBODY AND FC-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMOTOGRAPHY IV | GRAFFINITY PHARMACEUTICALS GMBH (DE) | 2013-08-15 | — | — | WO | disclosed |
| US-20130196979-A1 | Bicyclic Heteroaryl Compounds | ARIAD PHARMACEUTICALS, INC. (US) | 2013-08-01 | — | — | US | disclosed |
| EP-2240506-B1 | INHIBITORS OF IAP | GENENTECH INC (US) | 2012-12-26 | — | — | EP | disclosed |
| WO-2012020080-A2 | LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY II | GRAFFINITY PHARMACEUTICALS GMBH (DE) | 2012-02-16 | — | — | WO | disclosed |
| US-8101731-B2 | Yellow anionic disazo dyes | CIBA SPECIALTY CHEMICALS CORPORATION | 2012-01-24 | — | — | US | disclosed |
| WO-2010020366-A1 | AZABICYCLIC SUBSTITUTED 5-AMINOPYRAZOLES AND THE USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-02-25 | — | — | WO | disclosed |
| EP-1989204-A1 | PYRAZOLOQUINOLONES ARE POTENT PARP INHIBITORS | Abbott Laboratories (US) | 2008-11-12 | — | — | EP | disclosed |
| US-20080114158-A1 | Yellow anionic disazo dyes | LENNARTZ MICHAEL | 2008-05-15 | — | — | US | disclosed |
| US-7341607-B2 | Based on diaminobenzanilides or, more specifically (aminobenzoylamino),(sulfo-),(methoxy)anilines; stable aqueous solutions;nonbleeding/colorfastness; excellent degrees of exhaustion with high colour strength; dyeing natural or synthetic materials, particularly, paper; neutral or greenish-yellow hues | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-03-11 | — | — | US | disclosed |
| WO-2007095628-A1 | PYRAZOLOQUINOLONES ARE POTENT PARP INHIBITORS | ABBOTT LABORATORIES (US) | 2007-08-23 | — | — | WO | disclosed |
| US-20050172420-A1 | Yellow anionic disazo dyes | CIBA SPECIALTY CHEMICALS CORP. | 2005-08-11 | — | — | US | disclosed |
| EP-1509574-A1 | YELLOW ANIONIC DISAZO DYES | Ciba SC Holding AG (CH) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003104333-A1 | YELLOW ANIONIC DISAZO DYES | CIBA SPECIALTY CHEMICALS HOLDING, INC. (CH) | 2003-12-18 | — | — | WO | disclosed |
| WO-1998049219-A1 | PYRAZOL-BASED ELECTROLUMINESCENT POLYMERS AND THEIR USE IN ELECTROLUMINESCENT DEVICES | THE UNIVERSITY COURT OF NAPIER UNIVERSITY (GB) | 1998-11-05 | — | — | WO | disclosed |
| EP-0169813-A2 | Photographic recording material for the silver dye-bleaching process | CIBA-GEIGY AG (CH) | 1986-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130196979-A1 | Bicyclic Heteroaryl Compounds | CYP3A43, CYP11B2, CYP2F1 | MAPT 2300/4885ALDH1A1 636/4885TSHR 3513/4885 |
| US-20050172420-A1 | Yellow anionic disazo dyes | IK, CYB5R3, DCXR | MAPT 2297/4885ALDH1A1 3371/4885TSHR 3620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.